Urology for Practice, 2008, issue 2

Aktualita z Výboru ČUS

prof. MUDr. Tomáš Hanuš. DrSc

Urolog. pro Praxi, 2008; 9(2): 97-98

Editorial

Moderní urologie na prahu třetího tisíciletí

prof. MUDr. Jan Dvořáček DrSc

Urolog. pro Praxi, 2008; 9(2): 47-48

Review articles

Combined therapy of benign prostatic hyperplasia: yes or no?

MUDr. Jiří Klečka Ph.D, doc. MUDr. Milan Hora Ph.D, MUDr. Petr Běhounek

Urolog. pro Praxi, 2008; 9(2): 54-60

Medical therapy of lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH) with either alphalytics nor 5α reductase inhibitors has become the most common treatment choice over the past 15 years, replacing surgical procedures for BPH. Both classes of drugs have demonstrated officiality and safety in numerous placebo controlled, randomized clinical trials. Because of the two different mechanism of action proposed for these two classes of drugs the idea of utilizing both to enhance treatment efficacy appears promising. However, few well conducted trilas are available to adress issue of combination medical therapy of LUTS and BPH,...

Overactive bladder: cost-effectiveness of oxybutynin IR and solifenacin

MUDr. Jana Skoupá

Urolog. pro Praxi, 2008; 9(2): 61-63

The paper evaluates the cost-effectiveness in patients with an overactive bladder who are treated with either short-acting oxybutynin or solifenacin. In addition to medication costs, the costs also include treatments for some comorbidities such as depressions and urinary infections. The clinical outcome to which costs are related is achievement of continence.

Drugs influencing coagulation in urology

MUDr. Kamil Belej Ph.D., FEBU

Urolog. pro Praxi, 2008; 9(2): 64-68

Drugs affecting blood coagulation have been increasingly used to prevent and treat many vascular and haematologic diseases. Patients on these medication present management problems when attending for urological invasive procedures. There is no consensus of opinion on the appropriate management of these patients before and after surgery. In this article we review existing data on the management of these patients and we make some recommendations based on current knowledge. Until more information is available, those prescribing anticoagulants and those performing surgery must communicate with each other and team approach is crucial in order to achieve this.

Antibiotic treatment of community-acquired urinary tract infections

prof. MUDr. Milan Kolář Ph.D

Urolog. pro Praxi, 2008; 9(2): 69-70

Among common bacterial diseases in the community setting are urinary tract infections whose aetiological agents primarily include the strains of Escherichia coli and Proteus mirabilis. Treatment consists in administration of antibiotics with suitable preparations being cotrimoxazol, trimethoprim, nitrofurantoin, and amoxicillin.

The Most Frequent Viral Sexually Transmitted Diseases on Genitals, Differential Diagnosis and Treatment

MUDr. Klaudia Dvořáková

Urolog. pro Praxi, 2008; 9(2): 72-77

Viral infections localized on genitals belong into the group of the most frequent sexually transmitted diseases (STD) within the venereological office. Clinical manifestations including complications, which can result from negligence or improper treatment, are greatly traumatic and restrictive for the patient in her/his everyday life. According to the clinical findings we can divide the manifestations into papular, nodular, verrucose or erosive and ulcerous manifestations. The originators are the most commonly papilloma viruses (incidence approximately in 38 % of the population), herpes viruses and pox viruses. With respect to examination and...

Cardiovascular parameters of erectile dysfunction

MUDr. Taťána Šrámková CSc

Urolog. pro Praxi, 2008; 9(2): 78-81

Erectile dysfunction is a common problem of middle-aged and elderly men. The etiology is organic in about 80 % and the most frequent cause is cardiovascular. Erectile dysfunction and coronary artery disease have the same morphological base and hence the same risk factors. Therefore, coronary artery disease appears in patients with erectile dysfunction and vice versa. Erectile dysfunction can be included in the risk factors of coronary artery disease. That is why we should search for coronary artery disease in patients who have been diagnosed with erectile dysfunction. We should also actively screen these patients and treat them effectively.

Case report

Prostatický specifický antigen (PSA) a digitální rektální vyšetření (DRE) v diagnostice karcinomu prostaty

MUDr. Ivan Kolombo FEBU, MUDr. Martina Poršová, MUDr. Iva Zemanová, et al

Urolog. pro Praxi, 2008; 9(2): 83-88